BioSpace News Archive

CytoMed Therapeutics Limited (Nasdaq: GDTC) (“CytoMed” or the “Company”) today announced it has entered into a research collaboration agreement with The University of Texas MD Anderson Cancer Center (“MD Anderson”) in Houston, Texas.

Guardant Health, Inc. (Nasdaq: GH) today presented additional data from the ECLIPSE study at 2023 Digestive Disease Week (DDW) titled, “Clinical Validation of a Cell-Free DNA Blood-Based Test for Colorectal Cancer in an Average Risk Population” (Abstract #913e) showcasing the performance of its blood-based technology to accurately detect early-stage colorectal cancer (CRC).

The Insight Partners published latest research report on “Travel Vaccines Market Size Report, Share, Trends & Growth Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Application”,

Intelivation Technologies, a medical device company with a cutting-edge orthopedic and spine implant product portfolio announced that they have launched a new minimally invasive pedicle screw system.

High demand: Vetter expands production capacities and services offered at its Austrian site

The Sobi® AGM was convened on 9 May 2023. At the AGM, the shareholders, in accordance with the proposed resolutions.

Researchers at the University of Missouri Laboratory for Infectious Disease Research released the results of a study indicating that electroluminescent film technology, found in widely deployed biometric fingerprint scanners, actively kills SARS-CoV-2.

AB Science SA (Euronext - FR0010557264 - AB) today announces that Health Canada has issued a screening acceptance letter for the application of masitinib in the treatment of amyotrophic lateral sclerosis (ALS).

Royal Philips announced that ’s Annual General Meeting of Shareholders has reappointed Abhijit Bhattacharya for a two year’s term as member of the Board of Management fulfilling the role of CFO, and reappointed Liz Doherty and David Pyott as members of the Supervisory Board.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it will effect a 1-for-6.25 reverse stock split of its outstanding common stock.